Is HPV vaccination in pregnancy safe?
- PMID: 27172372
- PMCID: PMC4994723
- DOI: 10.1080/21645515.2016.1160178
Is HPV vaccination in pregnancy safe?
Abstract
Millions of doses of HPV vaccine have been administered globally. Inadvertent administration of HPV vaccine during pregnancy occurs given that the main recipients of the vaccine are fertile young women, who might be unaware of their pregnancy at the time of their vaccination. To investigate the subject of HPV vaccine and pregnancy , the databases of PubMed and Embase were searched to find the relevant literature published in English within the last 10 y. Most of the evidence pertaining to fetal adverse events following HPV vaccination relates to spontaneous miscarriage. None of the relevant studies found any significantly increased rate of spontaneous abortion in the overall analyses. There was no indication of other HPV vaccine-associated adverse events in pregnancy or immediately post-conception.
Keywords: HPV; adverse events; pregnancy; spontaneous abortion; vaccine.
Figures
Similar articles
-
Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013.Vaccine. 2015 Jan 15;33(4):519-22. doi: 10.1016/j.vaccine.2014.11.047. Epub 2014 Dec 8. Vaccine. 2015. PMID: 25500173 Free PMC article.
-
Safety of the HPV Bivalent and Quadrivalent Vaccines During Pregnancy.Ann Pharmacother. 2011 Feb;45(2):258-62. doi: 10.1345/aph.1P396. Ann Pharmacother. 2011. PMID: 21285408 Review.
-
Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.Hum Vaccin Immunother. 2014;10(9):2543-50. doi: 10.4161/21645515.2014.969618. Epub 2014 Nov 13. Hum Vaccin Immunother. 2014. PMID: 25483472 Free PMC article.
-
Is administration of the HPV vaccine during pregnancy feasible in the future?Expert Rev Vaccines. 2014 Feb;13(2):213-9. doi: 10.1586/14760584.2014.867236. Epub 2013 Nov 28. Expert Rev Vaccines. 2014. PMID: 24308583 Free PMC article. Review.
-
Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.Vaccine. 2018 Nov 12;36(46):7017-7024. doi: 10.1016/j.vaccine.2018.09.057. Epub 2018 Oct 9. Vaccine. 2018. PMID: 30314913 Free PMC article. Clinical Trial.
Cited by
-
'Does HPV affect my fertility?' Reproductive concerns of HPV-positive women: a qualitative study.Reprod Health. 2021 Apr 1;18(1):72. doi: 10.1186/s12978-021-01126-7. Reprod Health. 2021. PMID: 33794938 Free PMC article.
-
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.Vaccines (Basel). 2021 Nov 30;9(12):1413. doi: 10.3390/vaccines9121413. Vaccines (Basel). 2021. PMID: 34960159 Free PMC article. Review.
-
HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective.Virusdisease. 2023 May 24;34(2):1-19. doi: 10.1007/s13337-023-00824-z. Online ahead of print. Virusdisease. 2023. PMID: 37363362 Free PMC article. Review.
-
Maternal Vaccination as an Essential Component of Life-Course Immunization and Its Contribution to Preventive Neonatology.Int J Environ Res Public Health. 2018 Apr 25;15(5):847. doi: 10.3390/ijerph15050847. Int J Environ Res Public Health. 2018. PMID: 29693575 Free PMC article. Review.
-
Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.Hum Vaccin Immunother. 2020 Mar 3;16(3):581-589. doi: 10.1080/21645515.2019.1662363. Epub 2019 Oct 7. Hum Vaccin Immunother. 2020. PMID: 31486334 Free PMC article.
References
-
- al. Fe Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International journal of Cancer 2015; 136(5):E359-86. http://dx.doi.org/10.1002/ijc.29210; Epub 2014 Oct 9. - DOI - PubMed
-
- de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al.. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11:1048-56; PMID:20952254; http://dx.doi.org/10.1016/S1470-2045(10)70230-8 - DOI - PubMed
-
- Poland GA, Jacobson RM, Koutsky LA, Tamms GM, Railkar R, Smith JF, Bryan JT, Cavanaugh PF Jr., Jansen KU, Barr E. Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial. Mayo Clin Proc 2005; 80:601-10; PMID:15887427; http://dx.doi.org/10.4065/80.5.601 - DOI - PubMed
-
- Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr., Ngan Y, Petersen LK, Lazcano-Ponce E, et al.. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372:711-23; PMID:25693011; http://dx.doi.org/10.1056/NEJMoa1405044 - DOI - PubMed
-
- Human papillomavirus vaccines: WHO position paper, October 2014 Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations 2014; 89(43): 465-91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical